Subarachnoid Haemorrhage in Malta : Are outcomes adversely affected due to lack of a local neurovascular service? by Vella, Malcolm et al.
  
   
Original Article    
 
Malta Medical Journal    Volume 26 Issue 02 2014                                                                                                                
 
 
Abstract  
Objective: This study was performed to assess the 
incidence, treatment and outcome of non-traumatic 
Subarachnoid Haemorrhage (SAH) in an island which 
does not offer a neurovascular service and to determine 
whether such limitation is associated with a poor 
outcome. 
Method: Data of adult patients with a diagnosis of 
non-traumatic SAH was analysed retrospectively over a 
two-year period from January 01, 2009 to December 31, 
2010. 
 
 
 
 
Results: The incidence of SAH in Malta is 3.16 
cases per 100 000 population per year. An underlying 
aneurysm was found in 50% of all cases investigated 
with angiography. These patients were transported to the 
United Kingdom for definitve management and the 
outcome of all these patients at 6 months was excellent. 
(modified Rankin Scale of 0 or 1). 
Conclusions:  With the incidence of non-traumatic 
SAH being in the low range, setting up an interventional 
neuroradiology service in our country to treat 
aneurysmal SAH would not have the required numbers 
to maintain expertise and would probably translate into 
worse clinical outcomes. Despite having geographical 
and logistic limitations, our standards of care and 
survival rates are not below those of other international 
centres. Outcomes for patients with low initial Hunt and 
Hess scores have not been adversely affected by the lack 
of a local neurovascular service. 
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Introduction 
Subarachnoid haemorrhage (SAH) is a type of 
haemorrhagic stroke caused by bleeding into the 
subarachnoid space. The bleed can be secondary to 
trauma or non-traumatic.  Aneurysmal SAH is reported 
to be the cause in about 80% of non traumatic bleeds. 
The rest are caused by perimesencephalic haemorrhage, 
vessel abnormalities such as arterio-venous 
malformations and other rarer causes.1 Although SAH 
accounts for about 5% of all strokes, it is an important 
cause of stroke in young adults. The overall incidence is 
reported to be 6-10 per 100 000 per year. However, there 
is a significantly wide variation by region, as reported by 
a large World Health Organisation study where there 
was a 10-fold difference in incidence between countries 
from 2.0 per 100 000 in China to 22.5 per 100 000 in 
Finland.2 At younger ages, the incidence is higher in 
men, but becomes more common in women after the age 
of 55.3 SAH carries a significant mortality rate of up to 
50% with 10-15% dying prior to reaching hospital. In 
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surviving patients, there has been a decrease in overall 
mortality reported over the past 2 decades.4 
Malta has a population of 417, 432.5 No data is 
currently available on the incidence and outcomes of 
SAH in Malta. The purpose of our study is to assess the 
incidence, treatment and outcomes of SAH in the 
Maltese population. Also, in view of the lack of 
neurovascular services available in the country and the 
need for patients to be transported to a centre in the UK 
for definitive treatment, we aim to assess whether this 
has negatively affected outcomes.  
 
Study Methods 
All patients admitted with a suspected SAH on the 
Maltese Islands are treated at the main public hospital, 
Mater Dei Hospital (MDH) by one of three consultant 
Neurologists. If patients present to a private clinic they 
are quickly transferred to this general hospital for further 
investigation and management. There are no other 
facilities on the island equipped to treat these patients.  
Data of adult patients (>14 years of age) with a 
diagnosis of SAH from January 01, 2009 to December 
31, 2010 was collected and analysed from four separate 
sources – (i) Patients who were admitted through the 
Accident and Emergency department of Mater Dei 
Hospital (MDH) with a diagnosis of suspected SAH 
from the casualty admission register; (ii) Patients who 
were discharged from Mater Dei Hospital with a 
diagnosis of SAH were identified from the hospital 
activity analysis, using ICD9 coding system; (iii) 
Patients who were referred abroad for treatment of 
aneurysms were obtained from the Treatment Abroad 
Committee; (iv) Patients whose cause of death on the 
death   certificate   was   listed   as   “subarachnoid  
haemorrhage”  from  the  Death  Register.  All  patients  with  
a traumatic SAH were excluded.  
Only those patients who were not admitted to 
hospital because they died out-of-hospital or in the 
Accident and Emergency Department were solely 
identified from the death register. The rest of the patients 
were identified from more than one of the above 
mentioned sources, ensuring that data capture was 
thorough and complete. This data collection method 
guaranteed that no cases of SAH that were admitted to 
hospital were missed.  All the case notes, radiology, 
blood and cerebrospinal fluid results of these patients 
were analysed. 
 
Results 
The final number of patients with definite 
spontaneous non-traumatic SAH over the two-year study 
period was 26. Therefore the incidence of SAH in the 
Maltese population is calculated to be about 3.16 per 
100 000 population per year.  
 
 
Patient Characteristics 
Of these 26 patients, 18 (69%) were female and 8 
(31%) were male. The mean age was 55 (range 34-87) 
with a peak between 40-59 years of age.  
2 patients died before receiving medical attention 
and were certified dead from SAH according to their 
death certificate. One of these patients had a post-
mortem examination which confirmed SAH secondary 
to a ruptured berry aneurysm. The other patient had a CT 
scan carried out 2 weeks earlier which revealed a giant 
anterior communicating artery aneurysm. No further 
action was taken in this case because of co-morbidities. 
SAH was listed as the cause of death on the death 
certificate. Another patient, a 60 year old, died soon 
after presentation at the emergency deparment. This 
patient also had a postmortem examination which 
confirmed SAH as the cause of death. The data of these 
3 patients was not analysed further since the deaths were 
out of hospital or at the emergency department and no 
medical notes were available. (Figure 1) 
 
Presentation 
Almost all patients presented in the first 24 hours. 
One patient had symptoms suggestive of a sentinel bleed 
one week prior to presentation. All patients presented 
with an acute headache except the three who presented 
in a comatose or confused state. Other common 
symptoms at presentation were nausea and vomiting, 
confusion, reduced level of consciousness, motor 
weakness and seizures. Figure 2 demonstrates the Hunt 
and Hess  scores on admission.6 
 
 
Figure 1: Flow chart of patients with non-
traumatic SAH 
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Figure 2: Hunt and Hess Score on Admission 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk factors 
Risk Factors for SAH in our cohort were 
hypertension in 9 patients and smoking in 8 patients. 
One patient had immune thrombocytopenia and a 
myelodysplastic syndrome. 
 
Investigations 
Table 1 shows the investigations carried out on all 
patients with a diagnosis of spontaneous SAH. All 
patients had a non-contrast CT scan of the brain. SAH 
was confirmed in all cases except for one patient who 
had a normal CT. This patient had presented 5 days after 
the onset of headache.  
A lumbar puncture was carried out only in two 
cases. In one case a suspicion was raised over the 
diagnosis of SAH from brain CT and in the other case 
the CT was normal. In both cases xanthochromia was 
present confirming the diagnosis of SAH. 
Following a diagnosis of SAH from brain CT or 
lumbar puncture, 16 patients (70%), were investigated 
with further imaging modalities for the prescence of 
aneurysms. Further investigations consisted of a CT 
cerebral angiogram (CTA) in 9 patients; Magnetic 
Resonance Angiography (MRA) in 4 patients and 
Digital Subtraction Angiography (DSA) in 8 patients. 
The choice of the imaging modality after diagnosis of 
SAH was at the discretion of the caring consultant 
neurologist. If an aneurysm was identified on CTA or 
MRA, the patient was referred for coiling/clipping 
directly, and had a cerebral angiogram during pre-
operative planning. If no aneurysm was identified on 
CTA or MRA, the patient was further investigated with 
formal cerebral angiography.  
7 patients (30%) (patients 9, 10, 15, 20, 21, 22, 23 
in Table 1), did not have further investigations carried 
out because they were deemed unfit due to their low 
GCS on presentation or because of significant co-
morbities. These patients were treated conservatively. 
 
Management 
Most patients were admitted to the Neuromedical 
ward. Patients with a low GCS were admitted to 
Intensive Care. Treatment with nimodipine, lactulose 
and analgesia was initiated immediately in all cases 
upon diagnosis of SAH. Anticonvulsants were started 
only if the patient developed seizures. 
Of the 16 patients (See Figure 1) that were 
investigated with further imaging modalities for the 
possibility of an underlying aneurysm, 8 patients (50% 
of those investigated) were found to have one or more 
aneurysms. These patients were referred to the United 
Kingdom (UK) for definitive treatment of the aneurysm 
within an average of 4.4 days (2-13 days) from the day 
of admission. Only one out of these 8 patients required 
ITU admission and was transfered to the UK after 13 
days. The other 7 patients were transfered to the UK 
within an average of 3.1 days (2-4 days). 
Table 2 shows the site and size of the aneurysms 
identified in 8 patients from CTA, MRA or cerebral 
angiography carried out in Malta and in the UK. Of note, 
3 of these 8 patients had multiple aneurysms, although 
only the aneurysm suspected to have caused the SAH 
was treated with coiling or clipping. 6 patients with 
aneurysmal SAH were treated with coiling and aspirin ± 
clopidogrel for about 28 days. Only one patient 
underwent clipping of the aneursym. The decision to 
undergo coiling or clipping was decided by the caring 
Vascular Neurosurgeon in UK.   
The time elapsed from diagnosis of SAH to 
definitive treatment of the aneurysm in the UK was 5.4 
days (range 4-8 days). 
 
Length of stay 
The average total length of stay of patients with 
aneurysmal SAH from presentation until discharge from 
hospital was 17 days (14 - 20 days) with most patients 
being well enough to be discharged directly home from 
the UK hospital.  
The average length of stay of patients with angio-
negative SAH who survived the initial presentation was 
21 days (8 – 65 days). 
 
Outcome of SAH 
Complications occurring in patients with 
aneurysmal SAH treated with coiling or clipping 
There were no significant complications reported in 
the patients who underwent coiling or clipping except 
for a minor stroke in one patient, following which he 
made a full recovery. Another patient in this group 
developed Terson syndrome (vitreous haemorrhage 
associated with SAH). This patient also made a full 
recovery.  
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Table 1: Investigations carried out on patients with SAH 
 
 
Patient Non-contrast CT Lumbar  
Puncture 
CT Angiogram MRA Cerebral 
Angiogram 
 
1 SAH confirmed  Abnormal   
2 SAH confirmed  Abnormal   
3 SAH confirmed    Abnormal 
4 SAH confirmed  Abnormal   
5 SAH confirmed   Abnormal  
6 SAH confirmed   Normal Normal 
7 SAH confirmed  Normal  Normal 
8 SAH confirmed  Normal  Normal 
9  SAH confirmed     
10 SAH confirmed     
11 SAH confirmed Xanthochromia  Non-diagnostic Normal 
12 SAH confirmed  Normal   
13 Normal Xanthochromia Non-diagnostic  Normal 
14 SAH confirmed    Abnormal 
15 SAH confirmed     
16 SAH confirmed   Abnormal  
17 SAH confirmed  Abnormal   
18 SAH confirmed    Normal 
19 SAH confirmed  Normal   
20 SAH confirmed     
21 SAH confirmed     
22 SAH confirmed     
23 SAH confirmed     
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Table 2: Characteristics of the aneurysms and the management undertaken in UK 
 
Patient Investigations in Malta UK Definitive  CTA MRA Cerebral Angio Cerebral Angio Treatment 
1 3mm Basilar Tip   3mm Basilar Tip 3mm Paraopthalmic  Coiling + Aspirin 
2 6mm right Carotid Tip   P Comm  Coiling + Aspirin 
3   6mm left P Comm P Comm Left cavernous ICA Basilar fenestration 
Coiling + Aspirin 
4 6mm left MCA    N/A Clipping 
5  7mm left ACA  A Comm  Coiling + Aspirin 
14   Basilar Tip N/A N/A 
16  5mm A Comm  6mm A Comm Coiling + Aspirin 
17 4mm right vertebral 4mm left MCA 
  4mm right PICA  4mm left MCA 
Coiling + Aspirin 
MCA: middle cerebral artery 
P Comm: posterior communicating artery 
ACA: anterior cerebral artery 
A Comm: anterior communicating artery 
ICA: internal carotid artery 
N/A: data not available 
 
Complications occurring in patients with SAH who 
did not undergo coiling or clipping 
2 patients (9%) had a subarachnoid re-bleed, which 
occured after one day post-admission in one patient and 
after 3 days in the other patient. 4 patients (17%) 
developed hydrocephalus and 3 of these patients 
underwent VP shunting. 3 patients (13%) developed 
seizures. 2 patients developed sepsis/ventilator 
associated pneumonia. 1 patient developed pulmonary 
embolism and another patient developed a massive 
middle cerebral artery infarction.  
 
Post-treatment follow-up 
Patient 14 (Table 2) who was referred to the UK for 
definitive treatment of the aneurysm was of British 
nationality and did not return to Malta after transfer to 
the UK and was therefore lost to follow-up. The other 7 
patients who underwent coiling or clipping were 
followed up at Neurology out-patients for at least 6 
months. All 6 patients who underwent coiling had a 
repeat cerebral angiogram at 3 to 6 months post-
intervention. The angiogram revealed complete 
occlusion of the treated aneurysms in all cases. In one 
case the presence of another aneurysm was reported, but 
this was already reported in the CTA carried out on 
presentation with the SAH. Only the patient who 
underwent clipping of the aneurysm was not followed up 
with cerebral angiography.  
 
Mortality 
Excluding the British patient that was lost to 
follow-up, 22 patients were followed for at least 6 
months after the initial presentation with SAH or until 
the time of death. Out of these 22 patients, 7 patients 
(32%) died. All deaths occured as in-patient with an 
average of 16 days (2 – 37 days). The cause of death was 
directly related to SAH in 4 patients (raised intracranial 
pressure/coning) and secondary to ventilator associated 
pneumonia, pulmonary embolism and stroke in 3 
patients. All deaths occured in the patients who were 
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deemed not fit to undergo further investigations soon 
after admission (patients 9, 10, 15, 20, 21, 22, 23 in 
Table 1). 
Table 3 shows the Modified Rankin Score 6 months 
after the initial presentation for the 22 patients that were 
followed up for at least 6 months.  
 
Table 3: Modified Rankin Scale 
 
Scale Description No. of 
patients  
( /23)* 0 No symptoms 13 1 No significant disability. Able to carry out all usual activities, despite some symptoms 
2 
2 Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities 
0 
3 Moderate disability. Requires some help, but able to walk unassisted 0 4 Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted 
0 
5 Severe disability. Requires constant nursing care and attention, bedridden, incontinent 
0 
6 Dead 7 
adapted from  Farrell et al, 1991 (6) 
     * One patient lost to follow up 
 
Discussion 
MDH is the main acute hospital in the country. All 
patients diagnosed with SAH on the Maltese Islands are 
ultimately referred to MDH because it is the only 
hospital that offers the service of a critical care unit.  
The way the data was compiled in our study is 
representative of almost all the cases of SAH that 
occured in our country in the study period. The 
incidence of 3.16 per 100 000 population per year is on 
the low side of average incidence data. However, it 
further confirms the large variability across countries.2 
The Maltese population are mainly of Italian descent.8                             
 Recent epidemiological studies from Italy have also 
shown similar data.9-10 Reasons as to why the incidence 
is low could be due to the occurence of less risk factors, 
or genetics. Further demographics are all in keeping with 
international data, with the highest presentation being in 
the 40-59 years age group, and mainly female.  
MRA and CTA are being increasingly used as 
imaging modalities for the detection of intracranial 
aneurysms.11-12 Studies have reported sensitivity of CTA 
to be in the region of 95%, with a recent multicentre 
study reporting a sensitivity of 99%, comparable to 
DSA.12 However, if CTA is inconclusive, conventional 
DSA is still recommended.13 In our cohort, 50% of the 
patients investigated with angiography were found to 
have an aneurysm. This number is definitely an 
underestimate because it does not include those patients 
who did not undergo angiography. Theoretically, if all 
the patients who did not undergo angiography did 
actually have an aneurysm, this percentage would 
increase to 62%. Therefore comparison of the 
percentage of aneurysmal bleeds in our cohort with that 
of international figures unfortunately cannot be made.  
In Malta we do not have the facility of a 
neurovascular service mainly because of the limited 
number of SAH cases treated at our main hospital. We 
also lack the facility and expertise of an interventional 
neuroradiology service and since the number of cases is 
small, offering such a service would undoubtedly pose 
higher risks for the patients. This practice is in line with 
the latest American Heart Association/American Stroke 
Association guidelines which highlight the importance 
of specialised centres in the management of these 
patients. The recommendation is for low-volume 
hospitals with less than 10 cases of aneurysmal SAH per 
year to transfer patients to centres dealing with over 35 
cases per year as this has been shown to significantly 
improve outcomes.13-14 Malta has had very close medical 
ties with Britain for the past several years. There is an 
agreement between Malta and the UK stating that 
Maltese patients are treated in specialised centres in the 
UK should that service not be available locally, or local 
expertise is lacking. In view of the limited numbers of 
SAH  on  our   island,   these  patients’   treatment  falls  under  
this agreement. Patients are transported by air to 
specialised UK centres accompanied by a doctor and 
nurse escort. No complications were reported to have 
happened on the 3 hour flight to the UK. Emergency air 
medical transfer of patients with acute intra-cerebral 
bleed for definitive neurosurgical care appears to be both 
safe and effective, and facilitates early definitive 
diagnosis and operative intervention.15 
The International Subarachnoid Aneurysm Trial 
(ISAT) has shown a clear superiority of coiling over 
clipping in those aneurysms deemed to be suitable for 
both treatments and has definitively changed the practice 
in most neurovascular centres.16 In our study, all patients 
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except one had the aneurysm treated by endovascular 
coiling.  All these patients had a good outcome at 6 
months.  The decision as to which mode of treatment 
was employed was decided by the caring vascular 
neurosurgeon in the UK.  
Ideally, patients with SAH should be treated as 
early as feasible.13,17-18 Effort is made on our end to 
organise the transport of patients as soon as possible; 
however some delay is inevitable. Limitations to earlier 
treatment result from the logistics of the transfer itself as 
well as the clinical condition of the patient as some 
patients need stabilisation prior to air transfer.  In our 
patients, intervention was done at a mean of 5.4 days, 
having taken a mean of 4.4 days from the time of initial 
presentation to transfer to the UK. However, 
interventions done on our patients at slightly later times 
did not result in poor outcomes.  
There is no doubt that intervention on low-grade 
(Hunt and Hess score I-II) SAH patients reduces 
morbidity and mortality.13,16 Studies have shown a 
beneficial outcome in a proportion of aneurysmal SAH 
patients admitted with a poor grade.19-22 However, in 
some of these studies the authors have stated that there is 
an element of selection bias when choosing patients for 
intervention, whereby unstable patients were 
excluded.19,21-22 As yet, intervention for this patient 
group has not become established practice in all centres. 
If it can be proven conclusively that all patients with 
non-traumatic SAH should be treated acutely then it is 
essential to have a 24 hour endovascular service. 
Meanwhile, for the low grade patients it may be 
appropriate to refer them to centers that treat a larger 
number of cases per year. Indeed, this was proven in our 
study. 
This study was not designed to evaluate if the 
outcome of patients with aneurysmal SAH transferred to 
the UK is better than those treated locally, as we do not 
offer this neurovascular service. The main aim was to 
evaluate the need or otherwise for such a service to be 
developed in Malta. If the outcome for our patients 
needing transfer overseas for treament was shown to be 
poor, this would dictate the need for a local service. 
Unless the number of patients requiring endovascular 
treatment is significantly higher, it would not be justified 
to subject our patients to a poorer outcome due to 
limited expertise.  
The main limitation of this study is the small 
number of patients with SAH seen in our country, 
making this study low-powered. The incidence of 
aneurysms is probably higher than reported as poor 
grade patients were deemed too unfit for further 
investigation.  There is also underestimation if there 
were patients who died from SAH but this was not listed 
on the death certificate, especially if it was an out-of-
hospital death and the cause of death is not attributed to 
SAH but to a cardiac or other event. Unfortunately, this 
will remain a limitation in all similar studies.  
 
Conclusion 
In this study we have shown that the incidence of 
non-traumatic SAH in Malta is in the range of low-
incidence countries. Despite having small absolute 
numbers and logistic limitations for delivering definitive 
interventional treatment for aneurysmal bleeds, our 
standards of care and survival rates are not below those 
of other international centres for patients admitted with a 
low Hunt and Hess score. At present, the low number of 
non-traumatic SAH patients would not justify setting up 
an interventional neuroradiology service in our country 
to treat aneurysmal SAH. A local service would 
probably translate into worse clinical outcomes as the 
number of cases treated per year would be insufficient to 
maintain expertise.  
Further studies on the outcome of patients treated at 
different centres are required to determine the minimum 
number of cases that need to be treated at a specific 
center to significantly reduce the morbidity and 
mortality associated with the treatment of aneurysmal 
SAH. This would potentially set a threshold to determine 
the number of specialised neurovascular centers required 
in different countries to achieve the best clinical 
outcome.   
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